CRISPR Therapeutics (CRSP) Price Forecast: Dual Breakout Targets Higher Prices

Shares of CRISPR Therapeutics AG ( CRSP ), a clinical-stage gene-editing biopharmaceutical company, broke out of a multi-week consolidation range on Thursday with a rally above $59.49. The stock spiked by more than 10% intraday, reaching an 18-week high of $61.68 before encountering resistance. A weekly closing at $60.08 confirmed the breakout and leaves CRSP poised for further upside continuation. The breakout’s strength was supported by above-average 20-day volume of approximately 2.93 million shares. That was the second highest volume day since the beginning of June and the third highest since late April, indicating broader market participation. That expanding participation adds credibility to the breakout and supports the potential for the larger bullish reversal discussed below. CRSP daily chart shows breakouts of two inverse head and shoulders bullish patterns Fractal Bottoming Pattern Strengthens Bullish Case CRSP has been consolidating for several months while completing a bottoming process following the bearish correction from its prior trend high. It eventually formed a large inverse head and shoulders reversal pattern, with the March swing low at $44.12 forming the head and the neckline located...